JP2010511022A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010511022A5 JP2010511022A5 JP2009538758A JP2009538758A JP2010511022A5 JP 2010511022 A5 JP2010511022 A5 JP 2010511022A5 JP 2009538758 A JP2009538758 A JP 2009538758A JP 2009538758 A JP2009538758 A JP 2009538758A JP 2010511022 A5 JP2010511022 A5 JP 2010511022A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- ccid
- tetravalent
- chimeri
- den
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0655255A FR2909286B1 (fr) | 2006-12-01 | 2006-12-01 | Methode d'immunisation contre les 4 serotypes de la dengue |
| FR0655255 | 2006-12-01 | ||
| PCT/FR2007/052431 WO2008065315A1 (fr) | 2006-12-01 | 2007-11-30 | Methode d'immunisation contre les 4 serotypes de la dengue |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010511022A JP2010511022A (ja) | 2010-04-08 |
| JP2010511022A5 true JP2010511022A5 (cg-RX-API-DMAC7.html) | 2010-10-28 |
| JP5269803B2 JP5269803B2 (ja) | 2013-08-21 |
Family
ID=38198298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009538758A Expired - Fee Related JP5269803B2 (ja) | 2006-12-01 | 2007-11-30 | デング熱の４種の血清型に対する免疫付与のプロトコル |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US7718359B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2099483B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5269803B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20090087890A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101541344A (cg-RX-API-DMAC7.html) |
| AR (1) | AR064009A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007327367B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0718927A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2668570A1 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2909286B1 (cg-RX-API-DMAC7.html) |
| IL (2) | IL198466A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2009004223A (cg-RX-API-DMAC7.html) |
| MY (1) | MY180698A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI400249B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008065315A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200902540B (cg-RX-API-DMAC7.html) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5227172B2 (ja) * | 2005-08-10 | 2013-07-03 | サノフィ パスツール バイオロジクス リミテッド ライアビリティ カンパニー | デングウイルス感染に対するワクチン接種 |
| FR2903605A1 (fr) * | 2006-07-12 | 2008-01-18 | Sanofi Pasteur Sa | Methode d'immunisation contre les quatres serotypes de la dengue |
| FR2906724B1 (fr) * | 2006-10-04 | 2009-03-20 | Sanofi Pasteur Sa | Methode d'immunisation contre les 4 serotypes de la dengue. |
| ES2615390T3 (es) | 2008-03-05 | 2017-06-06 | Sanofi Pasteur | Proceso para estabilizar una composición de vacuna que contiene adyuvante |
| EP2143440A1 (fr) * | 2008-07-09 | 2010-01-13 | Sanofi Pasteur | Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués |
| MX343172B (es) * | 2009-06-01 | 2016-10-26 | Takeda Vaccines Inc | Composiciones y metodos para administracion de vacunas contra virus del dengue. |
| AU2010286368B2 (en) * | 2009-08-31 | 2015-09-03 | Gen-Probe Incorporated | Dengue virus assay |
| EP2353609A1 (en) | 2010-02-04 | 2011-08-10 | Sanofi Pasteur | Immunization compositions and methods |
| US8920813B2 (en) | 2010-12-20 | 2014-12-30 | Genvec, Inc. | Adenoviral vector-based dengue fever vaccine |
| US20150196631A1 (en) | 2012-07-24 | 2015-07-16 | Sanofi Pasteur | Vaccine compositions |
| PE20150356A1 (es) | 2012-07-24 | 2015-03-20 | Sanofi Pasteur | Composiciones de vacuna para la prevencion contra la infeccion por el virus del dengue |
| WO2014083194A1 (en) | 2012-11-30 | 2014-06-05 | Sanofi Pasteur | Methods for inducing antibodies |
| JP2016523251A (ja) * | 2013-06-21 | 2016-08-08 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | デングウイルスワクチン組成物およびその使用方法 |
| TWI852899B (zh) | 2014-09-02 | 2024-08-21 | 法商賽諾菲巴斯德公司 | 疫苗組合物 |
| US10857222B2 (en) | 2015-07-03 | 2020-12-08 | Sanofi Pasteur | Concomitant dengue and yellow fever vaccination |
| US10004795B2 (en) * | 2015-09-08 | 2018-06-26 | Fundacao Butantan | Process for preparing an attenuated tetravalent dengue vaccine |
| EP3691681A1 (en) | 2017-10-05 | 2020-08-12 | Sanofi Pasteur | Compositions for booster vaccination against dengu |
| PE20211545A1 (es) | 2018-09-05 | 2021-08-16 | Takeda Vaccines Inc | Dosis unitaria de vacuna contra el dengue y administracion de esta |
| CN114555113A (zh) | 2019-08-16 | 2022-05-27 | 武田疫苗股份有限公司 | 用于预防登革热和甲型肝炎的方法 |
| US20240076631A2 (en) | 2020-02-27 | 2024-03-07 | Takeda Vaccines, Inc. | Method for removing host cell dna from virus preparation |
| WO2023147337A2 (en) | 2022-01-25 | 2023-08-03 | Takeda Vaccines, Inc. | Large-scale flaviviral vaccine production and manufacture |
| US20250177511A1 (en) | 2022-02-15 | 2025-06-05 | Takeda Vaccines, Inc. | Dengue vaccine batch mixing process |
| WO2023215383A1 (en) | 2022-05-04 | 2023-11-09 | Takeda Vaccines, Inc. | Computer-based determination of flavivirus infectivity |
| EP4375381A1 (en) | 2022-11-18 | 2024-05-29 | Takeda Vaccines, Inc. | A method for determining the proportion of a live, attenuated flavivirus having a nucleotide sequence comprising at least one attenuation locus in a formulation |
| WO2024118740A1 (en) | 2022-11-29 | 2024-06-06 | Takeda Vaccines, Inc. | Large-scale flaviviral vaccine production and manufacture |
| WO2025072259A1 (en) | 2023-09-25 | 2025-04-03 | Takeda Vaccines, Inc. | Coadministration of tetravalent dengue vaccine with hpv vaccine |
| WO2025122855A1 (en) | 2023-12-08 | 2025-06-12 | Takeda Vaccines, Inc. | A method for determining the concentration of residual vero cell genomic dna in a sample containing virus obtained from production in vero cells |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1080370A4 (en) | 1998-05-29 | 2003-07-30 | Epimmune Inc | IDENTIFICATION OF RESILIENT DR EPITOPES LARGELY REACTIVE |
| WO2000057910A1 (en) | 1999-03-26 | 2000-10-05 | Walter Reed Army Institute Of Research | Attenuated dengue-4 virus vaccine |
| ES2322327T3 (es) * | 1999-03-26 | 2009-06-19 | Walter Reed Army Institute Of Research | Vacuna multivalente contra el virus del dengue. |
| US6632663B1 (en) | 1999-09-22 | 2003-10-14 | Aventis Pasteur Limited | DNA immunization against chlamydia infection |
| EP1263965B1 (en) * | 2000-02-16 | 2011-09-28 | The Government of the United States of America, as represented by the Secretary, Department of Health & Human Services | Avirulent, immunogenic flavivirus chimeras |
| EP1159969A1 (fr) | 2000-05-30 | 2001-12-05 | Aventis Pasteur | Vaccine composition |
| DK1159968T3 (da) * | 2000-05-30 | 2009-02-23 | Univ Mahidol | Attenuerede stammer af Dengue-virus og deres anvendelse i en vaccinesammensætning |
| WO2003101397A2 (en) * | 2002-05-31 | 2003-12-11 | Acambis, Inc. | Tetravalent dengue vaccines |
| BRPI0408774A (pt) * | 2003-03-24 | 2006-03-28 | Scripps Research Inst | vacinas de dna contra crescimento tumoral e seus usos |
| CA2611934C (en) * | 2005-06-17 | 2015-11-03 | Sanofi Pasteur | Dengue serotype 1 attenuated strain |
| ATE475706T1 (de) * | 2005-06-17 | 2010-08-15 | Sanofi Pasteur | Abgeschwächter dengue-serotyp-2-stamm |
| JP5227172B2 (ja) * | 2005-08-10 | 2013-07-03 | サノフィ パスツール バイオロジクス リミテッド ライアビリティ カンパニー | デングウイルス感染に対するワクチン接種 |
| US7968102B2 (en) * | 2006-01-13 | 2011-06-28 | Sanofi Pasteur S.A. | Dengue chimeric viruses |
| AR061197A1 (es) * | 2006-06-07 | 2008-08-13 | Sanofi Pasteur | Cepas del virus 3 del dengue vivas atenuadas |
| FR2903605A1 (fr) * | 2006-07-12 | 2008-01-18 | Sanofi Pasteur Sa | Methode d'immunisation contre les quatres serotypes de la dengue |
| FR2906724B1 (fr) * | 2006-10-04 | 2009-03-20 | Sanofi Pasteur Sa | Methode d'immunisation contre les 4 serotypes de la dengue. |
-
2006
- 2006-12-01 FR FR0655255A patent/FR2909286B1/fr not_active Expired - Fee Related
-
2007
- 2007-11-14 TW TW096143113A patent/TWI400249B/zh not_active IP Right Cessation
- 2007-11-21 US US11/944,311 patent/US7718359B2/en not_active Expired - Fee Related
- 2007-11-28 AR ARP070105280A patent/AR064009A1/es unknown
- 2007-11-30 BR BRPI0718927-3A2A patent/BRPI0718927A2/pt not_active IP Right Cessation
- 2007-11-30 EP EP07866551.0A patent/EP2099483B1/fr not_active Not-in-force
- 2007-11-30 AU AU2007327367A patent/AU2007327367B2/en not_active Ceased
- 2007-11-30 CN CNA2007800439553A patent/CN101541344A/zh active Pending
- 2007-11-30 MX MX2009004223A patent/MX2009004223A/es active IP Right Grant
- 2007-11-30 ZA ZA200902540A patent/ZA200902540B/xx unknown
- 2007-11-30 MY MYPI20091957A patent/MY180698A/en unknown
- 2007-11-30 CA CA002668570A patent/CA2668570A1/en not_active Abandoned
- 2007-11-30 WO PCT/FR2007/052431 patent/WO2008065315A1/fr not_active Ceased
- 2007-11-30 KR KR1020097010676A patent/KR20090087890A/ko not_active Abandoned
- 2007-11-30 JP JP2009538758A patent/JP5269803B2/ja not_active Expired - Fee Related
-
2009
- 2009-04-30 IL IL198466A patent/IL198466A/en not_active IP Right Cessation
-
2010
- 2010-03-05 US US12/718,931 patent/US20100239612A1/en not_active Abandoned
-
2013
- 2013-12-19 IL IL230052A patent/IL230052A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010511022A5 (cg-RX-API-DMAC7.html) | ||
| JP2010505801A5 (cg-RX-API-DMAC7.html) | ||
| MX2009004223A (es) | Protocolo de inmunizacion contra los 4 serotipos del dengue. | |
| WO2008022196A3 (en) | Development of dengue virus vaccine components | |
| JP2010521961A5 (cg-RX-API-DMAC7.html) | ||
| WO2010012069A8 (en) | Multivalent vaccines based on papaya mosaic virus and uses thereof | |
| JP2007538071A5 (cg-RX-API-DMAC7.html) | ||
| JP2011504486A5 (cg-RX-API-DMAC7.html) | ||
| Wong et al. | From bench to almost bedside: the long road to a licensed Ebola virus vaccine | |
| MX2010008468A (es) | Acidos nucleicos de la formula (i) (nug1xmgnnv)a y derivados de los mismos como un agente/adyuvante inmunoestimulante. | |
| JP2007302683A5 (cg-RX-API-DMAC7.html) | ||
| JP2009539965A5 (cg-RX-API-DMAC7.html) | ||
| JP2014520806A5 (cg-RX-API-DMAC7.html) | ||
| AR063057A1 (es) | Metodo de inmunizacion contra los 4 serotipos de dengue | |
| BRPI0908489A2 (pt) | uso de compostos químicos e método para desenhar compostos químicos que atenuam ou inibem a infecção pelo vírus da dengue | |
| CY1114298T1 (el) | Διαμορφωτικως περιορισμενα διφαινυλ παραγωγα για χρηση ως αναστολεις ιου ηπατιτιδας c | |
| CO6260103A2 (es) | Composiciones que comprenden antigenos neumococidos | |
| JP2007538072A5 (cg-RX-API-DMAC7.html) | ||
| NZ597000A (en) | Compositions and methods for administration of vaccines against dengue virus | |
| JP2017526689A5 (cg-RX-API-DMAC7.html) | ||
| WO2012075379A3 (en) | Liquid viral formulations | |
| JP2008531742A5 (cg-RX-API-DMAC7.html) | ||
| CO6541529A2 (es) | Método, plasmideo y composición para inducir una respuesta inmune contra virus de la dengue basado en vacunas de adn y virus quimericos | |
| JP2008514672A5 (cg-RX-API-DMAC7.html) | ||
| JP2006512078A5 (cg-RX-API-DMAC7.html) |